AI software assists in radiographic fracture detection
May 18, 2021Manufacturing and Production
GLEAMER’s BoneView, an artificial intelligence system, when combined with health professionals’ interpretations, lowered the false negative rate (undetected fractures) on …
Sandoz announces €150 million investment in antibiotic production
May 18, 2021Manufacturing and Production EU, manufacturing, production
Sandoz, a division of Novartis, has announced plans to develop its European antibiotics manufacturing network by expanding the production capabilities …
Asthma drug Dupixent sees positive results in child trials
May 18, 2021Manufacturing and Production FDA, asthma
Data presented at the 2021 American Thoracic Society International Conference from a Phase III trial of Dupixent (dupilumab) in children …
Pfizer-BioNTech vaccine can be kept in fridge longer than previously thought
May 18, 2021Manufacturing and Production
The EMA has extended the recommended approved storage period for an unopened thawed vial of the Pfizer-BioNTech vaccine from five …
Major UK study finds 96% people develop antibodies after one COVID-19 jab
May 18, 2021Manufacturing and Production
More than 96% of people develop antibodies after just one COVID-19 jab of either AstraZeneca or Pfizer, and almost 100% …
Sputnik V COVID-19 vaccine launched in India by Dr Reddy’s
May 17, 2021Sales and Marketing
Dr Reddy’s Laboratories has begun vaccinating in India with Russia’s COVID-19 vaccine as part of its soft launch after it …
Sanofi and GSK’s COVID-19 vaccine shows promising results in Phase II trial
May 17, 2021Sales and Marketing
The adjuvanted recombinant COVID-19 vaccine produced by Sanofi and GSK has demonstrated strong immune responses across all adult age groups …
Oxford University to collaborate with Oracle on COVID variant research
May 17, 2021Sales and Marketing AI, COVID-19, Oxford, variants
In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …
PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes
May 17, 2021Sales and Marketing AI, drug discovery
PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …
Biogen fails to meet primary endpoint in XLRP study
May 17, 2021Sales and Marketing Biogen, Clinical Trail
Biogen have released topline results from its Phase2/3 Xirius study of cotoretigene toliparvovec (BIIB112) as a gene therapy for patients …
Pharmafile.com’s top 10 news stories of the week
May 14, 2021Medical Communications
Among our ten most-read stories this week: India recoded its record number of COVID-19 deaths, with 4,205 fatalities confirmed in …
MSD’s colorectal cancer treatment approved by NICE
May 14, 2021Medical Communications
Pembrolizumab (Keytruda), for people with untreated metastatic colorectal cancer who have specific mutations in their cancer cells, has been approved …
Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows
May 14, 2021Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news
The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …
Biogen to collaborate with Envisagenics on RNA splicing research
May 14, 2021Medical Communications AI
Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …
Major ovarian cancer screening trial fails to reduce deaths
May 14, 2021Medical Communications
A major trial involving 200,000 women to detect ovarian cancer has failed to save lives after two decades of work. …
India approves Covaxin clinical trials for children aged 2-18 years old
May 13, 2021The Drugs Controller General of India (DCGI) has cleared Bharat Biotech’s Covaxin trials on children from 2-18 years old. The …
AstraZeneca and Amgen asthma drug shows positive results in Phase III trial
May 13, 2021Amgen, AstraZeneca, asthma, asthma treatment, pharma, pharma news, severe asthma
AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority across all primary and secondary …
Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer
May 13, 2021Libtayo, Sanofi, cemiplimab, cervical cancer
Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …
Rinri Therapeutics secures £3.2 million grant for hearing loss therapy
May 13, 2021Stem cells
Sheffield-based biotech company, Rinri Therapeutics, have secured a £3.2 million grant from Innovate UK to further develop Rinri’s novel stem …
Exscientia launch trial of third AI-designed molecule
May 13, 2021AI, Altzeimer's, Exscientia
Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …
Latest content
